Table 3 General information of subjects
Variable | Count (%) or Mean (SD) or Median (IOR) | |
|---|---|---|
Sex (Male) | 117 (68.40%) | |
Age,years | 67.5 (10.19) | |
Duration,years | 6 (1–15) | |
Smoking history | 115 (67.30%) | |
Smoking index (n = 115) | 800 (400–1000) | |
Exposures of noxious particles or gases | 118(69.00%) | |
EOS, * 10^6/L (n = 164) | 100 (22–200) | |
IgE,IU/ml | 95.10 (35.40–402) | |
Respiratory failure | 34 (19.9%) | |
IL-2,pg/ml (n = 162) | 515 (397–707) | |
IL-6,pg/ml (n = 162) | 3.485 (2–11.05) | |
IL-8,pg/ml (n = 162) | 20.1 (11.75–44.58) | |
TNF,pg/ml (n = 162) | 12.45 (8.03–22.05) | |
Positive results of allergens | 48 (28.1%) | |
Sum of positive allergen titers, IU/ml (n = 48) | 0.95 (0.63–4.09) | |
FEV1/FVC,% | 58.14 (13.95) | |
FEV1%pred,% | 56.67 (23.43) | |
RV/TLC,% | 54.13 (9.11) | |
FVC%pred,% | 74.4 (62–91) | |
FeNO,ppb (n = 170) | 23 (12–41.25) | |
Increased FEV1% after bronchodilation,% | 7.2 (3.6–15.5) | |
Increased FEV1 after bronchodilation,ml | 90 (40–190) | |
Very positive bronchodilator test | 8(4.7%) | |
Positive bronchodilator test | 37(21.6%) | |
Personal history of asthma | 56(30.9%) | |
High levels of total IgE | 81(47.4%) | |
Eosinophilia in sputum or high FeNO | 72(42.4%) | |
Health care utilisation in the past year | Hospitalised | 6 (3.5%) |
Emergency | 13 (7.6%) | |
Out patient | 152 (88.9) | |
Medication use | Oral or systemic CS | 13 (7.6%) |
ICS + LABA+LAMA | 37 (21.6%) | |
ICS + LABA | 55 (32.2%) | |
LAMA | 33 (19.3%) | |
Others | 33 (19.3%) | |